Skip to main content
Clinical Trials/NCT00449891
NCT00449891
Completed
Not Applicable

Neuropsychological and Neuroanatomical Studies of Young Children With and Without Type 1 Diabetes Mellitus

Stanford University1 site in 1 country30 target enrollmentJanuary 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 1 Diabetes Mellitus
Sponsor
Stanford University
Enrollment
30
Locations
1
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This study is being conducted to see if Type 1 diabetes mellitus has any affect on learning, behavior and development in young children and whether there are associated changes on their MRI scan.

Detailed Description

In this pilot study approximately 10-20 children between the ages of 3 to 10 years with Type 1 diabetes mellitus will have neuropsychological testing and a nonsedated MRI scan of the head performed every three years for three years. We will compare this to a control group of 10 children between the ages of 3 adn 10 years without Type 1 diabetes mellitus. The control subjects will neuropsychological testing and a nonsedated MRI scan of the head once. The children with Type 1 diabetes mellitus will not have any changes made to their current diabetes regimen.

Registry
clinicaltrials.gov
Start Date
January 2007
End Date
March 2016
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tandy Aye

Assistant Professor

Stanford University

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria for study subjects:
  • To be between ages 3 to 10 years
  • Have been diagnosed with type 1 diabetes for at least 6 months; and
  • Do not have plans to move out of the area within the next 36 months.
  • Inclusion Criteria for control subjects:
  • To be between ages 3 to 10 years

Exclusion Criteria

  • No history of head trauma with any loss of consciousness,
  • Cystic fibrosis,
  • Prematurity (born less than 30 weeks of gestation),
  • Significant developmental delay (lack of single word speech or ability to walk independently by 18 months of age),
  • Neurologic disease independent of diabetes (eg seizure disorder); or
  • Medical contraindication to MRI procedure (eg metal appliances such as braces).

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials